CAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears

The FDA is slated to decide on approving Capricor’s Deramiocel for the treatment of Duchenne muscular dystrophy by November 22.
Read the full report on Asianet Newsable
Story file
- Section
- Health
- First reported by
- Asianet Newsable
- Reporter
- stocktwits inc
- Published
- Thursday, 22 October 2026, 2:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.




